Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

164 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of Macitentan on the Development of New Ischemic Digital Ulcers in Patients With Systemic Sclerosis: DUAL-1 and DUAL-2 Randomized Clinical Trials.
Khanna D, Denton CP, Merkel PA, Krieg T, Le Brun FO, Marr A, Papadakis K, Pope J, Matucci-Cerinic M, Furst DE; DUAL-1 Investigators; DUAL-2 Investigators. Khanna D, et al. Among authors: papadakis k. JAMA. 2016 May 10;315(18):1975-88. doi: 10.1001/jama.2016.5258. JAMA. 2016. PMID: 27163986 Clinical Trial.
Evaluation of Macitentan in Patients With Eisenmenger Syndrome.
Gatzoulis MA, Landzberg M, Beghetti M, Berger RM, Efficace M, Gesang S, He J, Papadakis K, Pulido T, Galiè N; MAESTRO Study Investigators. Gatzoulis MA, et al. Among authors: papadakis k. Circulation. 2019 Jan 2;139(1):51-63. doi: 10.1161/CIRCULATIONAHA.118.033575. Circulation. 2019. PMID: 30586694 Free PMC article. Clinical Trial.
Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study.
Ghofrani HA, Simonneau G, D'Armini AM, Fedullo P, Howard LS, Jaïs X, Jenkins DP, Jing ZC, Madani MM, Martin N, Mayer E, Papadakis K, Richard D, Kim NH; MERIT study investigators. Ghofrani HA, et al. Among authors: papadakis k. Lancet Respir Med. 2017 Oct;5(10):785-794. doi: 10.1016/S2213-2600(17)30305-3. Epub 2017 Sep 11. Lancet Respir Med. 2017. Retracted and republished in: Lancet Respir Med. 2024 Apr;12(4):e21-e30. doi: 10.1016/S2213-2600(24)00027-4 Retraction in: Lancet Respir Med. 2024 Apr;12(4):262-263. doi: 10.1016/S2213-2600(24)00029-8 PMID: 28919201 Retracted and republished. Retracted. Clinical Trial.
Macitentan in pulmonary hypertension due to left ventricular dysfunction.
Vachiéry JL, Delcroix M, Al-Hiti H, Efficace M, Hutyra M, Lack G, Papadakis K, Rubin LJ. Vachiéry JL, et al. Among authors: papadakis k. Eur Respir J. 2018 Feb 7;51(2):1701886. doi: 10.1183/13993003.01886-2017. Print 2018 Feb. Eur Respir J. 2018. PMID: 29437943 Free article. Clinical Trial.
The efficacy of thymoxamine in primary Raynaud's phenomenon.
Grigg MJ, Nicolaides AN, Papadakis K, Wolfe JH. Grigg MJ, et al. Among authors: papadakis k. Eur J Vasc Surg. 1989 Aug;3(4):309-13. doi: 10.1016/s0950-821x(89)80066-0. Eur J Vasc Surg. 1989. PMID: 2527760 Clinical Trial.
Cariprazine in the treatment of schizophrenia: a proof-of-concept trial.
Durgam S, Litman RE, Papadakis K, Li D, Németh G, Laszlovszky I. Durgam S, et al. Among authors: papadakis k. Int Clin Psychopharmacol. 2016 Mar;31(2):61-8. doi: 10.1097/YIC.0000000000000110. Int Clin Psychopharmacol. 2016. PMID: 26655732 Free PMC article. Clinical Trial.
164 results